Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease

Novel biomarkers may improve our ability to predict which patients with chronic kidney disease (CKD) are at higher risk for progressive loss of renal function. Here we assessed the performance of urine neutrophil gelatinase-associated lipocalin (NGAL) for outcome prediction in a diverse cohort of 33...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Kathleen D, Yang, Wei, Anderson, Amanda H, Feldman, Harold I, Demirjian, Sevag, Hamano, Takayuki, He, Jiang, Lash, James, Lustigova, Eva, Rosas, Sylvia E, Simonson, Michael S, Tao, Kaixiang, Hsu, Chi-yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642209/
https://www.ncbi.nlm.nih.gov/pubmed/23344473
http://dx.doi.org/10.1038/ki.2012.458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3642209/
https://www.ncbi.nlm.nih.gov/pubmed/23344473
http://dx.doi.org/10.1038/ki.2012.458

Ejemplares similares